Cargando…
Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005
According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide valifenalate. To assess the occurrence of valifenalate residues in plants, processed commodities, rotational crops and livestock, EFSA...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108061/ https://www.ncbi.nlm.nih.gov/pubmed/33976719 http://dx.doi.org/10.2903/j.efsa.2021.6591 |
_version_ | 1783690064212000768 |
---|---|
author | Anastassiadou, Maria Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Vagenende, Benedicte Verani, Alessia |
author_facet | Anastassiadou, Maria Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Vagenende, Benedicte Verani, Alessia |
collection | PubMed |
description | According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide valifenalate. To assess the occurrence of valifenalate residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, as well as European authorisations reported by Member States and the UK (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was missing. Hence, the consumer risk assessment is considered indicative only and one MRL proposal derived by EFSA still requires further consideration by risk managers. |
format | Online Article Text |
id | pubmed-8108061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81080612021-05-10 Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 Anastassiadou, Maria Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Vagenende, Benedicte Verani, Alessia EFSA J Reasoned Opinion According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide valifenalate. To assess the occurrence of valifenalate residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, as well as European authorisations reported by Member States and the UK (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was missing. Hence, the consumer risk assessment is considered indicative only and one MRL proposal derived by EFSA still requires further consideration by risk managers. John Wiley and Sons Inc. 2021-05-10 /pmc/articles/PMC8108061/ /pubmed/33976719 http://dx.doi.org/10.2903/j.efsa.2021.6591 Text en © 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Reasoned Opinion Anastassiadou, Maria Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Carrasco Cabrera, Luis Ferreira, Lucien Greco, Luna Jarrah, Samira Kazocina, Aija Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Vagenende, Benedicte Verani, Alessia Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 |
title | Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 |
title_full | Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 |
title_fullStr | Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 |
title_full_unstemmed | Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 |
title_short | Review of the existing maximum residue levels for valifenalate according to Article 12 of Regulation (EC) No 396/2005 |
title_sort | review of the existing maximum residue levels for valifenalate according to article 12 of regulation (ec) no 396/2005 |
topic | Reasoned Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108061/ https://www.ncbi.nlm.nih.gov/pubmed/33976719 http://dx.doi.org/10.2903/j.efsa.2021.6591 |
work_keys_str_mv | AT reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT anastassiadoumaria reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT bellisaigiulia reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT bernasconigiovanni reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT brancatoalba reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT carrascocabreraluis reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT ferreiralucien reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT grecoluna reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT jarrahsamira reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT kazocinaaija reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT leuschnerrenata reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT magransjoseoriol reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT mironileana reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT navestefanie reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT pedersenragnor reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT reichhermine reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT santosmiguel reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT scarlatoalessiapia reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT theobaldanne reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT vagenendebenedicte reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 AT veranialessia reviewoftheexistingmaximumresiduelevelsforvalifenalateaccordingtoarticle12ofregulationecno3962005 |